decreased circulating glucagon level_Tg(Myl2-FGF19)1Dfre/?

http://metadb.riken.jp/0002696IFVBTgMyl2FGF191DfreTgMyl2FGF191Dfre

decreased circulating glucagon level_Tg(Myl2-FGF19)1Dfre/?

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, Dorothy M French
  http://metadb.riken.jp/db/mgi_rdf/MGI:3621047

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Myl2-FGF19)1Dfre/?

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Myl2-FGF19)1Dfre

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased circulating glucagon level
  http://purl.obolibrary.org/obo/MP_0002696

文献

http://purl.org/net/cito/citesAsAuthority

• Elizabeth. Tomlinson, et.al., Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity., Endocrinology, 2002, 143
  http://rdf.ncbi.nlm.nih.gov/pubmed/11956156